for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

OncoQuest Pharmaceuticals Inc

078590.KQ

Latest Trade

3,890.00KRW

Change

0.00(0.00%)

Volume

2,812,103

Today's Range

3,135.00

 - 

4,655.00

52 Week Range

3,135.00

 - 

6,820.00

As of on the KOSDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
3,890.00
Open
4,435.00
Volume
2,812,103
3M AVG Volume
0.00
Today's High
4,655.00
Today's Low
3,135.00
52 Week High
6,820.00
52 Week Low
3,135.00
Shares Out (MIL)
82.92
Market Cap (MIL)
322,897.10
Forward P/E
--
Dividend (Yield %)
--

Next Event

OncoQuest Pharmaceuticals Inc Annual Shareholders Meeting

Latest Developments

More

OncoQuest Signs Deal To Sell Drug Portfolio To Dual Industrial For $300 Mln

Dual Industrial appoints Park Jae Jin and Byun Tae Woong as co-CEO

Dual Industrial says conversion of 3rd series convertible bonds into shares

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About OncoQuest Pharmaceuticals Inc

OncoQuest Pharmaceuticals Inc, formerly Dual Industrial Co Ltd, is a Korea-based company principally engaged in the manufacture and sale of carpets for automobiles. The Company mainly provides car interior carpet products such as car seat fabrics, car seat coverings, car seat moldings and air bags used for passenger cars and recreational vehicles. The Company sells its products in domestic and overseas markets.

Industry

Auto & Truck Parts

Contact Info

670-21, Sannae-ro, Sannae-myeon

50414

South Korea

+82.2.69252168

https://diac.co.kr/

Executive Leadership

Chang Hyeon Lee

Chief Executive Officer, Director

Sang Eon Park

Internal Auditor

Gi Hyeon Han

Director

Beom Sang Goh

Non-Executive Independent Director

Key Stats

Price To Earnings (TTM)
--
Price To Sales (TTM)
4.82
Price To Book (MRQ)
11.51
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
22.01
LT Debt To Equity (MRQ)
10.62
Return on Investment (TTM)
-322.49
Return on Equity (TTM)
-119.84

Latest News

Latest News

BRIEF-OncoQuest Signs Deal To Sell Drug Portfolio To Dual Industrial For $300 Mln

* ONCOQUEST SIGNS A DEFINITIVE AGREEMENT TO SELL DRUG PORTFOLIO TO DUAL INDUSTRIAL FOR U.S. $300 MILLION AND COMMITMENT TO FUND THE OREGOVOMAB PHASE 3 CLINICAL TRIAL IN FRONTLINE OVARIAN CANCER

S.Korea stocks bounce back; Fed in focus

Round-up of South Korean financial markets:

S.Korea stocks rebound as Fed comes into focus

* KOSPI index climbs, foreigners net buyers * Korean won strengthens versus U.S. dollar * South Korea benchmark bond yield rises SEOUL, July 30 (Reuters) - Round-up of South Korean financial markets: South Korean shares on Tuesday rebounded from a sharp decline in the previous...

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up